Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation

Journal of the American Veterinary Medical Association

Volumn 228, Issue 10, 2006, Pages 1559-1564

  Ficken, Martin D ^a,b   Ellsworth, Michael A ^a   Tucker, Cassius M ^a   Cortese, Victor S ^a  

^a PFIZER INC   (United States)

^b Benchmark BioLabs Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE DIARRHEA VIRUS VACCINE; LIVE VACCINE; MODIFIED LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BOVINE DIARRHEA VIRUS; BREEDING; CATTLE DISEASE; CHILDBIRTH; CONTROLLED STUDY; DRUG EFFICACY; EVALUATION; FEMALE; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; NONHUMAN; PREGNANCY; PROGENY; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL DISEASES; IMMUNOHISTOCHEMISTRY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, ANIMAL; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 33646562817     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.10.1559     Document Type: Article

References (17)

1. Cortese VS, Grooms DL, Ellis JA, et al. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of modified-live virus vaccine. Am J Vet Res 1998;59:1409-1413.
2. McClurkin AW, Littledike ET, Cutlip RC, et al. Production of cattle immunotolerant to bovine viral diarrhea virus (BVDV). Can J Comp Med 1984;48:156-161.
3. Ficken M, Jeevaerathnam S, Wen Welch SK, et al. BVDV fetal infection with selected isolates. In: International symposium: bovine viral diarrhea virus: a 50 year review. Ithaca, NY: Cornell University Press, 1996;110-112.
4. Kaeberle ML, Maxwell D, Johnson E. Efficacy of inactivated bovine viral diarrhea virus vaccines in a cow herd. In: Animal science leaflet R 701. Ames, Iowa: Iowa State University Press, 1990;42-43.
5. Meyling A, Rensholt L, Dalsgaard K, et al. Experimental exposure of vaccinated and non-vaccinated pregnant cattle to isolates of bovine viral diarrhea virus (BVDV), in Proceedings. Commission Eur Communities Semin Res Anim Husbandry 1987;225-231.
6. Harkness JW, Roeder PL, Drew T, et al. The efficacy of an experimental inactivated BVD-MD vaccine, in Proceedings. Commission Eur Communities Semin Res Anim Husbandry 1987;233-250.
7. Brownlie J, Clarke MC, Hooper LB, et al. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec 1995;137:58-62.
8. Frey HR, Eicken K. Untersuchungen über die Wirksamkeit einer inaktivierten BVD-Vakzine zur Erhöhung der Sicherheit einer BVD-Lebendvakzine. Ticrarztl Umsch 1995;50:86-93.
9. Cortese VS, West KH, Hassard LE, et al. Clinical and Immunologic responses of vaccinated and unvaccinated calves to infection with a virulent type-II isolate of bovine viral diarrhea virus. J Am Vet Med Assoc 1998;213:1312-1319.
10. Dean HJ, Leyh RL. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 1999;17:1117-1124.
11. Makoschey B, Janssen MG, Vrijenhoek MP, et al. An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine 2001;19:3261-3268.
12. Shimazaki T, Nakamura S, Taguchi K, et al. Efficacy of bovine viral diarrhea vaccine used in Japan against bovine viral diarrhea virus type 2 strain 890. J Vet Med Sci 2003;65:263-266.
13. Fairbanks K, Schnackel J, Chase CC. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge. Vet Ther 2003;4:24-34.
14. Brock KV, Cortese VS. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2001;2:354-360.
15. Fairbanks KK, Rinehart CL, Ohnesorge WC, et al. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. J Am Vet Med Assoc 2004;225:1898-1903.
16. Kovacs F, Magyar T, Rinehart C, et al. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Vet Microbiol 2003;96: 117-131.
17. SAS/STAT procedures guide. Cary, NC: SAS Institute Inc.